More articles from Bronchiectasis

Tiotropium treatment for bronchiectasis: a randomised, placebo-controlled, crossover trial
Lata Jayaram, Alain C. Vandal, Catherina L. Chang, Chris Lewis, Cecilia Tong, Christine Tuffery, Jill Bell, Wendy Fergusson, Gene Jeon, David Milne, Stuart Jones, Noel Karalus, Sandra Hotu, Conroy Wong

European Respiratory Journal Jun 2022, 59 (6) 2102184; DOI: 10.1183/13993003.02184-2021
Heterogeneity of treatment response in bronchiectasis clinical trials
Oriol Sibila, Elena Laserna, Amelia Shoemark, Lidia Perea, Diana Bilton, Megan L. Crichton, Anthony De Soyza, Wim G. Boersma, Josje Altenburg, James D. Chalmers

European Respiratory Journal May 2022, 59 (5) 2100777; DOI: 10.1183/13993003.00777-2021
Psychometrics of health-related quality of life questionnaires in bronchiectasis: a systematic review and meta-analysis
Rebecca H. McLeese, Arietta Spinou, Zina Alfahl, Michail Tsagris, J. Stuart Elborn, James D. Chalmers, Anthony De Soyza, Michael R. Loebinger, Surinder S. Birring, Konstantinos C. Fragkos, Robert Wilson, Katherine O'Neill, Judy M. Bradley

European Respiratory Journal Nov 2021, 58 (5) 2100025; DOI: 10.1183/13993003.00025-2021
Validation of the Bronchiectasis Impact Measure (BIM): a novel patient-reported outcome measure
Megan L. Crichton, Emily K. Dudgeon, Amelia Shoemark, James D. Chalmers

European Respiratory Journal May 2021, 57 (5) 2003156; DOI: 10.1183/13993003.03156-2020
Efficacy and safety of TOBI Podhaler in Pseudomonas aeruginosa-infected bronchiectasis patients: iBEST study
Michael R. Loebinger, Eva Polverino, James D. Chalmers, Harm A.W.M. Tiddens, Herman Goossens, Michael Tunney, Felix C. Ringshausen, Adam T. Hill, Rashidkhan Pathan, Gerhild Angyalosi, Francesco Blasi, Stuart J. Elborn, Charles S. Haworth

European Respiratory Journal Jan 2021, 57 (1) 2001451; DOI: 10.1183/13993003.01451-2020
Sputum neutrophil elastase associates with microbiota and Pseudomonas aeruginosa in bronchiectasis
Martina Oriano, Andrea Gramegna, Leonardo Terranova, Giovanni Sotgiu, Imran Sulaiman, Luca Ruggiero, Laura Saderi, Benjamin Wu, James D. Chalmers, Leopoldo N. Segal, Paola Marchisio, Francesco Blasi, Stefano Aliberti

European Respiratory Journal Oct 2020, 56 (4) 2000769; DOI: 10.1183/13993003.00769-2020
Changes in respiratory symptoms during 48-week treatment with ARD-3150 (inhaled liposomal ciprofloxacin) in bronchiectasis: results from the ORBIT-3 and -4 studies
James D. Chalmers, David Cipolla, Bruce Thompson, Angela M. Davis, Anne O'Donnell, Gregory Tino, Igor Gonda, Charles Haworth, Juergen Froehlich

European Respiratory Journal Oct 2020, 56 (4) 2000110; DOI: 10.1183/13993003.00110-2020
Inhaled aztreonam improves symptoms of cough and sputum production in patients with bronchiectasis: a post hoc analysis of the AIR-BX studies
Megan L. Crichton, Mike Lonergan, Alan F. Barker, Oriol Sibila, Pieter Goeminne, Amelia Shoemark, James D. Chalmers

European Respiratory Journal Jul 2020, 56 (1) 2000608; DOI: 10.1183/13993003.00608-2020
Association between physical activity and risk of hospitalisation in bronchiectasis
Victoria Alcaraz-Serrano, Elena Gimeno-Santos, Giulia Scioscia, Albert Gabarrús, Adria Navarro, Beatriz Herrero-Cortina, Rosanel Amaro, Laia Fernández-Barat, Antoni Torres

European Respiratory Journal Jun 2020, 55 (6) 1902138; DOI: 10.1183/13993003.02138-2019
Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis
Emily Henkle, Jeffrey R. Curtis, Lang Chen, Benjamin Chan, Timothy R. Aksamit, Charles L. Daley, David E. Griffith, Kevin L. Winthrop

European Respiratory Journal Jul 2019, 54 (1) 1801896; DOI: 10.1183/13993003.01896-2018

Main menu

User menu

Search

More articles from Bronchiectasis

Pages

Contact us